Pharmaceuticals - San Diego, California, United States
The Verdin team is focused on developing meaningful medications capable of reducing the suffering and injury associated with gout and its consequences. We are developing small molecule uricosuric agents that enhance uric acid excretion lowering serum uric acid (sUA) for the treatment of chronic gout.